Roger Dmochowski, MD
Urology · Nashville, TNNPI 1508953613
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $659,522 of the $763,323 with a category attached, or 86.4%. Bluewind Medical accounts for 71.3% of it on its own, with 27 other manufacturers making up the rest. Among urology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 283 payments — averaging $2697.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bluewind Medical$544K
- Caldera Medical, Inc$51K
- Boston Scientific$42K
- Astellas Pharma Inc$17K
- Contura, Inc.$16K
- Axonics, Inc.$12K
- plus $81K from 22 others
Across 23 payments — averaging $1762.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$21K
- Cook Research Incorporated$8K
- Cytyc Surgical Products, LLC$7K
- Seikagaku Corporation$3K
- Taiho Oncology, Inc.$700
- Ipsen Innovation$629
- plus $585 from 1 others
What the payments were for
- Consulting fees$659,52286%
- Speaking & faculty fees$2,6500%
- Grants$1,4210%
- Travel & lodging$50,2497%
- Food & beverage$6,3921%
- Education$3,5750%
- Ownership interest$36,6415%
- Other$2,8730%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bluewind Medical | 161 | $544,178 |
| Caldera Medical, Inc | 8 | $51,250 |
| Boston Scientific | 10 | $41,849 |
| Astellas Pharma Inc | 4 | $16,849 |
| Contura, Inc. | 11 | $16,391 |
| Axonics, Inc. | 25 | $11,542 |
| Sumitomo Pharma America, Inc. | 3 | $10,340 |
| AbbVie(2 entities) | 13 | $9,985 |
| AMAG Pharmaceuticals, Inc. | 1 | $9,250 |
| Merck | 5 | $7,575 |
| Imbrium Therapeutics L.p. | 2 | $7,175 |
| Uromedica, Incorporated | 3 | $6,087 |
| Purdue Pharma L.p. | 1 | $5,200 |
| Coloplast | 7 | $4,331 |
| HRA Pharma | 1 | $4,250 |
| Neotract Inc. | 1 | $3,200 |
| Bayer | 1 | $3,200 |
| Urovant Sciences Inc | 2 | $3,160 |
| Medtronic(2 entities) | 11 | $2,178 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $1,300 |
| GSK | 3 | $1,050 |
| Hologic Sales And Service, LLC | 2 | $741 |
| Laborie Medical Technologies Corp. | 1 | $700 |
| Shionogi Inc | 1 | $635 |
| Renovia Inc | 1 | $359 |
| Teleflex LLC | 1 | $350 |
| Johnson & Johnson | 2 | $164 |
| BD | 1 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REVI$367,577
- RENOVA$110,471
- Desara$51,250
- GENERAL - THERAPIES$39,514
- Bulkamid$16,894
- MYRBETRIQ$16,826
- Axonics r-SNM System$10,291
- BOTOX$9,447
- MAKENA$9,250
- GEMTESA$8,800
- MK-7264$7,575
- ProACT$6,000
- UroLift$3,200
- Axonics$2,556
- INTERSTIM$2,055
- Luja Coude$1,720
- Optilume Urethral Drug Coated Balloon$700
- Leva Pelvic Floor Trainer$359
- Barrigel$350
How this compares
$763,323 in reported general payments places this provider in the 95th percentile of 276 urology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 126 | $121,705 |
| GemtesaVibegron | 85 | $72,059 |
| Trospium Chloride ErTrospium Chloride | 36 | $6,462 |
| Estradiol | 40 | $2,519 |
| Tamsulosin Hcl | 53 | $1,438 |
| Methenamine Hippurate | 32 | $1,329 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $582 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 22 | $280 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 41 | $147 |
| Ciprofloxacin Hcl | 27 | $93 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $72 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $10,340 | $72,05985 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 276 urology providers in Tennessee.
Other urology in Nashville
- L KnollNashville$2.1M
- Gautam JayramNashville$1M
- Ashley TapscottNashville$425K
- Raoul ConcepcionNashville$339K
- Melissa KaufmanNashville$312K
- Sam ChangNashville$198K
- Benjamin DehnerNashville$165K
- Smita deNashville$100K
- Nicole MillerNashville$73K
- Kelvin MosesNashville$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.